- Home
- TLS vs ARTV Comparison
TLS vs ARTV Comparison
Compare TLS & ARTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLS
- ARTV
- Stock Information
- Founded
- TLS 1969
- ARTV 2019
- Country
- TLS United States
- ARTV United States
- Employees
- TLS N/A
- ARTV N/A
- Industry
- TLS EDP Services
- ARTV
- Sector
- TLS Technology
- ARTV
- Exchange
- TLS Nasdaq
- ARTV NYSE
- Market Cap
- TLS 198.1M
- ARTV 186.1M
- IPO Year
- TLS 2020
- ARTV 2024
- Fundamental
- Price
- TLS $2.46
- ARTV $3.16
- Analyst Decision
- TLS Buy
- ARTV Strong Buy
- Analyst Count
- TLS 6
- ARTV 7
- Target Price
- TLS $4.13
- ARTV $20.00
- AVG Volume (30 Days)
- TLS 343.6K
- ARTV 144.2K
- Earning Date
- TLS 03-10-2025
- ARTV 05-22-2025
- Dividend Yield
- TLS N/A
- ARTV N/A
- EPS Growth
- TLS N/A
- ARTV N/A
- EPS
- TLS N/A
- ARTV N/A
- Revenue
- TLS $108,272,000.00
- ARTV $251,000.00
- Revenue This Year
- TLS $38.54
- ARTV N/A
- Revenue Next Year
- TLS $36.17
- ARTV N/A
- P/E Ratio
- TLS N/A
- ARTV N/A
- Revenue Growth
- TLS N/A
- ARTV N/A
- 52 Week Low
- TLS $1.89
- ARTV $3.15
- 52 Week High
- TLS $5.03
- ARTV $17.31
- Technical
- Relative Strength Index (RSI)
- TLS 30.97
- ARTV N/A
- Support Level
- TLS $2.62
- ARTV N/A
- Resistance Level
- TLS $2.84
- ARTV N/A
- Average True Range (ATR)
- TLS 0.14
- ARTV 0.00
- MACD
- TLS -0.01
- ARTV 0.00
- Stochastic Oscillator
- TLS 7.14
- ARTV 0.00
About TLS Telos Corporation
Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials.